MyFastRx Review

MyFastRx: the cheapest compounded GLP-1 if you'll pay a year upfront

MyFastRx is a cash-pay telehealth platform built around one idea: get you approved fast and reward you for committing long-term. Its headline rate of $99 a month for compounded semaglutide is among the lowest published prices we track — but that number only appears if you prepay a full twelve months at once. Pay month to month and you'll spend considerably more. So the real question isn't whether MyFastRx is cheap. It's whether betting a year of treatment on a provider that keeps a lot of its operation undisclosed makes sense for you. For the right patient, the math is genuinely attractive. For everyone else, the trade-offs deserve a hard look.

How the bundle pricing actually works

MyFastRx uses a tiered ladder where the price drops the longer you commit. Compounded semaglutide starts at a standard monthly rate and steps down through three-month and six-month plans to $99 a month on the twelve-month bundle. Compounded tirzepatide follows the same structure at a higher price point, landing in the mid-hundreds per month on the full-year plan. A first-month promo code (SAVE70) knocks the opening payment down to lower the trial barrier.

The catch is right there in the structure: those best-case numbers are billed upfront, all twelve months at once. That's a large single charge to a provider whose pharmacy partner and medical director aren't named publicly. The standard month-to-month rate is real and still reasonable, but it's nowhere near the figure the homepage leads with. For context, the $169 category median sits between MyFastRx's standard and bundle rates — so this provider is a genuine value play only if you go long.

Flat dosing is the underrated win here

One feature that quietly favors patients: every dose costs the same. Many compounded-GLP-1 sellers raise your monthly bill as you titrate up to higher strengths, which punishes you precisely as the medication starts working. MyFastRx prices all doses identically. Starting low or already at a maintenance dose, your rate doesn't move. Over a year of dose escalation, that flat structure can save real money compared with a provider that charges by strength — and it makes budgeting predictable, which matters when you've already prepaid.

What you actually get

• Compounded semaglutide or compounded tirzepatide, injectable
• A doctor consultation included — no separate visit fee
• Free discreet shipping nationwide
• The same price at every dose as you titrate up
• A tiered discount that rewards 3-, 6-, or 12-month commitments

The medications and how they're dispensed

MyFastRx deals exclusively in compounded versions of semaglutide and tirzepatide — the same active ingredients as the brand-name injectables, prepared by a compounding pharmacy rather than the original manufacturer. There's no brand-name Wegovy, Zepbound, or Ozempic option here, and no oral pill; this is injectable compounded medication only. The consultation and shipping are bundled into the price, so the monthly figure is close to your all-in cost rather than a teaser that balloons at checkout.

What MyFastRx will not tell you is which pharmacy makes your medication. The site references 'state-licensed pharmacies' but names no specific 503A or 503B partner. For a compounded product — where the pharmacy IS the quality control — that opacity is a meaningful gap. You're trusting the platform's vetting without being able to check the source yourself.

Trust and safety: a mixed picture

On the positive side, MyFastRx is LegitScript-certified, which is a real credential — it means a third party reviewed the operation for compliance with pharmacy and telehealth rules. The platform is HIPAA-compliant and operates as a registered corporate entity. There are no FDA warning letters on file against it, and it claims to work through licensed U.S. providers across all states.

But the disclosure gaps hold it back: the specific states served aren't enumerated, no medical director is named, no corporate address is published, and the pharmacy partner is anonymous. None of these is individually disqualifying, but together they mean you're extending more trust than a fully transparent provider would ask for. Our scoring methodology treats undisclosed oversight as a real cost, and MyFastRx pays it. The pricing is published verbatim and the LegitScript listing checks out, but the people and places behind the brand stay in the shadows.

Who should choose it — and who should skip it

Choose MyFastRx if you're a cash-pay patient who has already decided you're in this for the long haul, you're comfortable paying a full year upfront, and the lowest possible monthly rate is your top priority. The flat per-dose pricing and bundled consult make it especially good for someone who expects to titrate to a higher maintenance dose and wants their cost locked in.

Skip it if you want to start month-to-month and see how you respond before committing — the standard rate erases much of the advantage. Skip it if you need insurance billing, since MyFastRx is cash-pay only and won't coordinate coverage. And skip it if undisclosed oversight is a dealbreaker for you: a named pharmacy and a published medical director are things some competitors offer, and if that transparency matters, you can find it elsewhere.

Bottom line

MyFastRx earns its place as a value option for committed, cash-pay GLP-1 patients. The twelve-month bundle rate of $99 for compounded semaglutide is legitimately competitive, and flat dosing is a patient-friendly touch too few providers offer. But the price you see advertised is the long-commitment price, and the company asks for that commitment while keeping its pharmacy, medical leadership, and state footprint private. If you go in clear-eyed — prepaying a year to a LegitScript-listed but partly opaque platform in exchange for a low rate — it can be a smart deal. If any of that gives you pause, a more transparent provider is worth the few extra dollars.

Shopping around? Embody ($79/month) and bmiMD ($99/month) are the nearest alternatives to MyFastRx in our rankings.